We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
-10.89%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
10 Year Est. Return
AUM
$238M
AUM Growth
-$44.7M
Cap. Flow
+$5.43M
Cap. Flow %
2.28%
Top 10 Hldgs %
35.96%
Holding
100
New
14
Increased
24
Reduced
28
Closed
7

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$5.72M
2
TSEM icon
Tower Semiconductor
TSEM
+$4.29M
3
NVO
Novo Nordisk
NVO
+$3.9M
4
LULU icon
lululemon athletica
LULU
+$3.89M
5
AMZN icon
Amazon
AMZN
+$3.63M

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$4.66M
2
PG icon
Procter & Gamble
PG
+$4.25M
3
DHR icon
Danaher
DHR
+$3.77M
4
ISRG icon
Intuitive Surgical
ISRG
+$3.76M
5
UNH icon
UnitedHealth
UNH
+$3.45M

Sector Composition

Rank Sector Weight
1 Technology 39.05%
2 Consumer Discretionary 21.48%
3 Healthcare 19.9%
4 Communication Services 6.97%
5 Financials 2.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RGEN icon
76
Repligen
RGEN
$9.35B
$91K 0.04%
563
-8,376
-94% -$1.32M
CRSP icon
77
CRISPR Therapeutics
CRSP
$5.22B
$81K 0.03%
1,333
DNA icon
78
Ginkgo Bioworks
DNA
$486M
$71K 0.03%
745
ILMN icon
79
Illumina
ILMN
$29.1B
$38K 0.02%
211
-719
-77% -$184K
BEKE icon
80
KE Holdings
BEKE
$19.2B
$27K 0.01%
+1,479
New +$20.8K
GH icon
81
Guardant Health
GH
$22.2B
$23K 0.01%
581
BABA icon
82
Alibaba
BABA
$300B
$22K 0.01%
194
-3,753
-95% -$368K
CRL icon
83
Charles River Laboratories
CRL
$13.6B
$19K 0.01%
89
-3,125
-97% -$764K
IQV icon
84
IQVIA
IQV
$39.8B
$18K 0.01%
84
-789
-90% -$171K
TXG icon
85
10x Genomics
TXG
$7.52B
$15K 0.01%
322
-9,037
-97% -$469K
VEEV icon
86
Veeva Systems
VEEV
$39.2B
$11K ﹤0.01%
55
STAA icon
87
STAAR Surgical
STAA
$1.27B
$10K ﹤0.01%
136
NTLA icon
88
Intellia Therapeutics
NTLA
$1.69B
$8K ﹤0.01%
154
QTRX icon
89
Quanterix
QTRX
$139M
$7K ﹤0.01%
415
LRCX icon
90
Lam Research
LRCX
$408B
-41,500
Closed -$1.98M
EXAS
91
DELISTED
Exact Sciences
EXAS
$5K ﹤0.01%
128
NVAX icon
92
Novavax
NVAX
$1.31B
$3K ﹤0.01%
56
PYPL icon
93
PayPal
PYPL
$50.6B
$2K ﹤0.01%
+34
New +$2.95K
SDGR icon
94
Schrodinger
SDGR
$1.39B
$1K ﹤0.01%
48
NFLX icon
95
Netflix
NFLX
$309B
-1,530
Closed -$57K
PG icon
96
Procter & Gamble
PG
$335B
-27,825
Closed -$4.25M
TXN icon
97
Texas Instruments
TXN
$253B
-10,000
Closed -$1.83M
WMT icon
98
Walmart Inc
WMT
$923B
-93,960
Closed -$4.66M
MRTX
99
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-247
Closed -$20K
ZEN
100
DELISTED
ZENDESK INC
ZEN
-17,600
Closed -$2.12M

Similar funds

China Universal Asset Management Company's Q2 2022 Portfolio in Review

As of Q2 2022, China Universal Asset Management Company held 100 positions worth $238M, down 16% from $282M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

China Universal Asset Management Company's Q2 2022 filing shows 14 new, 24 increased, 28 reduced and 7 closed positions. Its largest new stake was Tower Semiconductor: 90,000 shares worth $4.16M. The largest sale was Walmart Inc, an estimated $4.66M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • China Universal Asset Management Company's largest Q2 2022 buy was Tower Semiconductor: 90,000 shares worth $4.16M.
  • China Universal Asset Management Company added most to Merck in Q2 2022, an estimated $5.72M increase.
  • China Universal Asset Management Company's biggest Q2 2022 reduction was Danaher, cutting an estimated $3.77M.
  • China Universal Asset Management Company fully exited Walmart Inc in Q2 2022, selling an estimated $4.66M.
  • China Universal Asset Management Company's ten largest holdings make up 36% of its $238M portfolio in Q2 2022.
  • China Universal Asset Management Company opened 14 new positions and closed 7 in Q2 2022.
  • China Universal Asset Management Company's portfolio value fell 16% quarter-over-quarter to $238M.

Based on China Universal Asset Management Company's 13F filing for Q2 2022, filed 12 Aug 2022.